EssilorLuxottica: EssilorLuxottica 2019 Annual General Meeting
EssilorLuxottica 2019 Annual General Meeting
- Adoption of all Board’s resolutions at ordinary and extraordinary General Meeting
- Rejection of the two additional resolutions proposed by certain shareholders
- Dividend payment of Euro 2.04 per share
Charenton-le-Pont, France (May 16, 2019 – 8:00 pm) – EssilorLuxottica’s Annual General Meeting was held today at the Maison de la Mutualité in Paris, chaired by Leonardo Del Vecchio, Executive Chairman, and Hubert Sagnières, Executive Vice-Chairman, of EssilorLuxottica.
EssilorLuxottica shareholders approved all 18 resolutions, at the ordinary and extraordinary General Meeting, which had been submitted by the Board of Directors (and published in compliance with the provisions of the law).
This especially includes the approval of the payment of a dividend of Euro 2.04 per ordinary share for the 2018 fiscal year. Ex-date: May 21, 2019. Date of payment: May 23, 2019.
Furthermore, EssilorLuxottica shareholders rejected two additional resolutions, which had been added on the agenda of the Annual General Meeting following requests from some of the Company’s shareholders received on April 18, 2019.
EssilorLuxottica shareholders have been informed of the appointment of Laurent Vacherot, CEO of Essilor International, as a Director of EssilorLuxottica, replacing Bernard Hours, who has asked to be relieved of his office. The Group would like to extend its thanks to Bernard Hours for his contribution to the work of EssilorLuxottica’s Board of Directors. Laurent Vacherot’s appointment will be submitted for ratification by the shareholders at the next Annual General Meeting.
Additionally, the Board of Directors held yesterday made the following decisions regarding the composition of the Board’s Committees. Cristina Scocchia, Juliette Favre and Laurent Vacherot enter the Strategic Committee, the latter replacing Bernard Hours. Finally, Annette Messemer replaces Bernard Hours in the Nominations Committee.
“We want to thank all shareholders who are supporting our project, including the funds that brought to the attention of the General Meeting additional resolutions and issues that will serve as a stimulus to improve and to act in the best interests of EssilorLuxottica. The agreement we have signed goes in this direction. From today’s General Meeting, we move forward strengthened with the belief that this combination is destined to redefine the entire industry for the benefit of all its stakeholders.” commented Leonardo Del Vecchio, Executive Chairman of EssilorLuxottica.
“With the second shareholders’ meeting held today, we are further consolidating the basis of EssilorLuxottica’s integration, and we are moving forward with the simplification of the combined Group. Together with the recently announced agreement, we are now in a better position to ramp up our growth, take advantage of emerging opportunities and deliver on our mission,” stated Hubert Sagnières, Executive Vice-Chairman of EssilorLuxottica.
EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world to see more, be more and live life to its fullest by addressing their evolving vision needs and personal style aspirations. The company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux® and Transitions®, and world-class retail brands including Sunglass Hut and LensCrafters are part of the EssilorLuxottica family. In 2018, EssilorLuxottica had nearly 150,000 employees and pro forma consolidated revenues of Euro 16.2 billion.
The EssilorLuxottica share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP.
|EssilorLuxottica Investor Relations|
(Charenton-le-Pont) Tel: + 33 1 49 77 42 16
(Milan) Tel: + 39 (02) 8633 4870
|EssilorLuxottica Corporate Communications|
(Charenton-le-Pont) Tel: + 33 1 49 77 45 02
(Milan) Tel: + 39 (02) 8633 4470
Upcoming Life Sciences Events
- September 2019
- Munich: The Biotech & Pharma Summit: Drug Delivery & Formulation
- Brussels: The Pharma Forecasting Course
- Bangkok: Bio Investment Asia 2019